Zhejiang Orient Gene Biotech Co., Ltd

SHSE:688298 Stock Report

Market Cap: CN¥3.6b

Zhejiang Orient Gene Biotech Balance Sheet Health

Financial Health criteria checks 4/6

Zhejiang Orient Gene Biotech has a total shareholder equity of CN¥7.2B and total debt of CN¥536.0M, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are CN¥8.4B and CN¥1.3B respectively.

Key information

7.5%

Debt to equity ratio

CN¥535.98m

Debt

Interest coverage ration/a
CashCN¥3.95b
EquityCN¥7.19b
Total liabilitiesCN¥1.26b
Total assetsCN¥8.44b

Recent financial health updates

Recent updates

Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) Weighed On By Its Debt Load?

Aug 20
Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) Weighed On By Its Debt Load?

Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) A Risky Investment?

Apr 30
Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: 688298's short term assets (CN¥4.8B) exceed its short term liabilities (CN¥1.2B).

Long Term Liabilities: 688298's short term assets (CN¥4.8B) exceed its long term liabilities (CN¥69.6M).


Debt to Equity History and Analysis

Debt Level: 688298 has more cash than its total debt.

Reducing Debt: 688298's debt to equity ratio has reduced from 13.6% to 7.5% over the past 5 years.

Debt Coverage: 688298's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 688298's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies